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Abstract: Chronic adenoiditis occurs frequently in children, and it is complicated by the subsequent
development of recurrent or chronic middle ear diseases, such as recurrent acute otitis media,
persistent otitis media with effusion and chronic otitis media, which may predispose a child to
long-term functional sequalae and auditory impairment. Children with chronic adenoidal disease
who fail to respond to traditional antibiotic therapy are usually candidates for surgery under general
anaesthesia. It has been suggested that the ineffectiveness of antibiotic therapy in children with
chronic adenoiditis is partially related to nasopharyngeal bacterial biofilms, which play a role in the
development of chronic nasopharyngeal inflammation due to chronic adenoiditis, which is possibly
associated with chronic or recurrent middle ear disease. This paper reviews the current evidence
concerning the involvement of bacterial biofilms in the development of chronic adenoiditis and
related middle ear infections in children.
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1. Introduction
Chronic adenoiditis is frequent in children, mainly affecting those aged 3–7 years [1]. The
adenoidal pads are located at the dome of the nasopharynx, and the enlargement of lymphoid tissue
during childhood may contribute to the development of repeated nasopharyngeal infections, sleep
disorders or middle ear infections after Eustachian tube orifice obstruction [2].
Bacterial biofilms may be involved in the pathogenesis of chronic adenoiditis, as they may be
present throughout the nasopharyngeal mucosa, and particularly in the lateral portion of adenoidal
pads extending towards the orifice of the Eustachian tube.
Given the close anatomical and functional relationship between the nasopharynx and the middle
ear (adenoidal pads may laterally extend to the ostium of the Eustachian tube), chronic adenoiditis is
often complicated by the development of chronic or recurrent middle ear disease [3–5], which may
manifest itself as persistent serous or mucous fluid in the middle ear (chronic otitis media with effusion,
OME), repeated acute middle ear infections (recurrent acute otitis media, RAOM), or long-lasting
middle ear suppuration through chronic perforation of the tympanic membrane (chronic suppurative
otitis media, CSOM) [3–5]. Chronic OME is defined as documented as middle ear effusion without any
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sign of concomitant acute middle ear inflammation persisting for at least three months [4]; RAOM is
defined as at least three episodes of acute otitis media within a period of six months, or more than four
episodes in a period of 12 months [3]; and CSOM is defined as the presence of a long-lasting purulent
ear discharge through a persistent perforation of the tympanic membrane [5]. Each of these conditions
may significantly affect a patient’s quality of life and possibly predispose them to long-term functional
sequelae and serious complications such as mastoiditis, meningitis, cerebral abscess, and lateral sinus
thrombosis and auditory impairment [5]. A better understanding of the pathogenic mechanisms
underlying these diseases would help to reduce their incidence and their related complications.
The bacteria mainly involved in the pathogenesis of acute and recurrent otitis media are the
so-called otopathogens—Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae—but
Staphylococcus aureus may also be involved, albeit less frequently [6,7]. Chronic otitis media is generally
sustained by non-typeable Haemophilus influenzae, Pseudomonas aeruginosa and Staphylococcus aureus [8],
and chronic nasopharyngitis and adenoiditis are due to the otopathogens Staphylococcus aureus,
Pseudomonas aeruginosa and Haemophilus parainfluenzae [9].
It has been suggested that the lack of response to antibiotic therapy in children with chronic
adenoiditis is partially attributable to the presence of nasopharyngeal bacterial biofilms, which may
play a pathogenic role in the development of chronic nasopharyngeal inflammation due to chronic
adenoiditis and are possibly associated with chronic or recurrent middle ear disease [9–13]. The
failure of traditional antibiotic treatment is related to the resistance of bacterial biofilm, which is
partially due to the physical barrier formed by the extracellular matrix, which blocks antibiotic diffusion
within the biofilm, as well as some particular characteristics of the biofilms themselves [10], such
as reduced bacterial replication in the inner layers and resistance mechanisms acquired as a result
of the quorum-sensing process. Although various alternative conservative treatments have been
tested (including manuka honey, baby shampoo, and hyaluronic acid- or acetylcysteine-based topical
treatments), there is no evidence that they are effective in vivo.
Given the largely ineffective nature of traditional antibiotic therapy, children with chronic
adenoiditis (with or without middle ear involvement) are generally candidates for surgical treatment
under general anaesthesia, including adenoidectomy and myringotomy, with or without the placement
of a ventilation tube [14]. However, although the definitive treatment is surgical debridement, no clinical
studies have investigated possible post-surgical changes in nasopharyngeal and middle ear biofilms.
This paper discusses current evidence concerning the involvement of bacterial biofilms in chronic
adenoiditis and recurrent or chronic middle ear infections in children: English language papers
concerning the possible role of bacterial biofilms in chronic adenoidal and middle ear disease that
were published between 1 January 2007 and 1 January 2019 were selected after a MEDLINE search
(accessed via PubMed). Separate systematic literature searches were made for chronic adenoiditis and
middle ear disease (i.e., OME, RAOM and CSOM). Consideration was only given to fully accessible,
original in vivo studies [9,11,12,15–31] published in peer-reviewed journals that specifically concerned
the role of bacterial biofilm in chronic adenoiditis and recurrent/chronic middle ear disease in children.
In vitro, ex vivo and animal studies, reviews and papers that did not clearly report the prevalence of
bacterial biofilm involvement in their case series were excluded.
2. Bacterial Biofilms in Chronic Adenoiditis and Sampling Procedures
The literature search used the following terms: “biofilm AND nasopharyngitis”, “biofilm AND
nasopharynx”, “biofilm AND adenoid”, and “biofilm AND adenoiditis”. This review was based on
eight [9,11,12,15–19] of the 37 initially identified papers concerning chronic adenoiditis and included a
total of 496 paediatric patients (Figure 1).
J. Clin. Med. 2019, 8, 671 3 of 12
J. Clin. Med. 2019, 8, x FOR PEER REVIEW 6 of 13 
 
2. Bacterial Biofilms in Chronic Adenoiditis and Sampling Procedures 
The literature search used the following terms: “biofilm AND nasopharyngitis”, “biofilm AND 
nasopharynx”, “biofilm AND adenoid”, and “biofilm AND adenoiditis”. This review was based on 
eight [9,11,12,15–19] of the 37 initially identified papers concerning chronic adenoiditis and included 
a total of 496 paediatric patients (Figure 1).  
 
Figure 1. Flowchart of article selection (biofilms in chronic adenoiditis). 
The microbiological analyses of adenoid biopsies (collected during surgery) and nasopharyngeal 
swabs were made by means of spectrophotometry or other advanced microbiological techniques 
(scanning electron microscopy, fluorescence in situ hybridisation). 
Analysis of the currently available literature suggests that the adenoids and surrounding 
nasopharyngeal mucosa are frequently covered by polymicrobial biofilm, and thus possibly act as an 
infectious focus in some cases. Bacterial biofilm can be found in up to 100% of nasopharyngeal 
samples taken from children with chronic nasopharyngeal infections. However, the reported 
prevalence rate varies widely (41%–100%) (Table 1) depending on the case series and the sampling 
and microbiological analysis techniques used [9,11,12,15–19]. The main bacteria involved were 
shown to be the otopathogens (M. catarrhalis, H. influenzae, S. pneumoniae), S. pyogenes, S. aureus and 
P. aeruginosa. Table 1 shows the main characteristics of the selected case series and the related 
microbiological findings. 
The microbiological analyses of nasopharyngeal specimens, which generally used 
spectrophotometry, scanning electron microscopy or fluorescence in situ hybridisation, showed that 
the main bacteria involved in nasopharyngeal biofilm production are the otopathogens (H. influenzae, 
M. catarrhalis and S. pneumoniae) [9–13], which are also responsible for middle ear infections. 
The spectrophotometric method requires the incubation of bacterial cultures with appropriate 
growth medium in order to ensure biofilm development, after which the growth medium is 
discarded, each well is washed to eliminate any unbound bacteria, the adherent organisms are 
stained with crystal violet and any excess stain is rinsed away. Once the plates have been dried, the 
optical densities (ODs) of the stained adherent bacterial biofilms are measured using a microplate 
reader in order to assess bacterial adherence and biofilm formation [9]. 
Scanning electron microscopy of adenoidal specimens follows the method used by Hoa et al. 
[32]: the tissue samples are fixed, washed, dehydrated and coated for final imaging preparation and 
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The microbiological analyses of adenoid biopsies (collected during surgery) and nasopharyngeal
swabs were made by means of spectrophotometry or other advanced microbiological techniques
(scanning electron microscopy, fluorescence in situ hybridisation).
Analysis of the currently available literature suggests that the adenoids and surrounding
nasopharyngeal mucosa are frequently covered by polymicrobial biofilm, and thus possibly act as an
infectious focus in some cases. Bacterial biofilm can be found in up to 100% of nasopharyngeal samples
taken from children with chronic nasopharyngeal infections. However, the reported prevalence rate
varies widely (41%–100%) (Table 1) depending on the case series and the sampling and microbiological
analysis techniques used [9,11,12,15–19]. The main bacteria involved were shown to be the otopathogens
(M. catarrhalis, H. influenzae, S. pneumoniae), S. pyogenes, S. aureus and P. aeruginosa. Table 1 shows the
main characteristics of the selected case series and the related microbiological findings.
The microbiological analyses of nasopharyngeal specimens, which generally used
spectrophotometry, scanning electron microscopy or fluorescence in situ hybridisation, showed that
the main bacteria involved in nasopharyngeal biofilm production are the otopathogens (H. influenzae,
M. catarrhalis and S. pneumoniae) [9–13], which are also responsible for middle ear infections.
The spectrophotometric method requires the incubation of bacterial cultures with appropriate
growth medium in order to ensure biofilm development, after which the growth medium is discarded,
each well is washed to eliminate any unbound bacteria, the adherent organisms are stained with crystal
violet and any excess stain is rinsed away. Once the plates have been dried, the optical densities (ODs)
of the stained adherent bacterial biofilms are measured using a microplate reader in order to assess
bacterial adherence and biofilm formation [9].
Scanning electron microscopy of adenoidal specimens follows the method used by Hoa et al. [32]:
the tissue samples are fixed, washed, dehydrated and coated for final imaging preparation and then
imaged at a resolution of 1000× in order to study the biofilm architecture and analyse it using dedicated
image analysis software.
The fluorescence in situ hybridisation of adenoidal samples with pathogen-specific 16S rRNA
probes was described by Hoa et al. [32] as follows: specimens are fixed, washed and incubated, and
then probed for H. influenzae, S. pneumoniae, M. catarrhalis and S. aureus, or using a universal eubacterial
16S rRNA probe.
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Table 1. Main characteristics and related microbiological findings of the main studies of bacterial biofilm in chronic adenoiditis.
Authors; Year No. of Patients;Samples
Mean Age ± SD,
years Analytical Technique
Prevalence of Bacterial
Biofilm (%) Prevalence of Isolated BPB
Galli et al. [15], 2007 15; 15 - SEM 100
H. influenzae = 67%
S. pyogenese = 7%
Alpha-hemolytic streptococcus i = 13%
Al-Mazrou et al. [16], 2008 76; 76 (adenoids andtonsils) 5.7 ± 3.3 SEM 85 Staphylococcus spp. and Streptococcus spp.
Winther et al. [17], 2009 -; 9 - PAS of Carnoy fluid andFISH 91 -
Torretta et al. [9], 2011 42; 84 7.0 ± 2.7 Spectrophotometry BPB in 74 NPS and 69 B
S. aureus = 55% (NPS); 79% (B)
M. catarrhalis = 19% (NPS); 21% (B)
H. influenzae = 10% (NPS); 14% (B)
S. pneumoniae = 35% (NPS); 10% (B)
P. aeruginosa = 3% (NPS); 10% (B)
S. pyogenes = 10% (NPS); 7% (B)
H. parainfluenzae = 23% (NPS); 0% (B)
Torretta et al. [12], 2012 113; - Median: 40 (range:10–132), months Spectrophotometry
BPO in 41 patients with
recurrent middle ear
infections and 14 controls
M. catarrhalis = 6 (patients); 34 (controls)
S. pneumoniae = 17 (patients); 33 (controls)
S. pyogenes = 6 (patients); 33 (controls)
H. influenzae= 71 (patients); 0 (controls)
Torretta et al. [11], 2013 45; 135 Median: 7 (range:4–13) Spectrophotometry BPB in 72 (ET); 53 (NPD)
S. aureus = 45% (ET); 50% (NPD)
S. pneumoniae = 18% (ET); 12% (NPD)
M. catarrhalis = 20% (ET); 12% (NPD)
S. pyogenes = 9% (ET); 9% (NPD)
H. influenzae = 3% (ET); 4% (NPD)
Coagulase negative staphylococci = 3% (ET);
4% (NPD)
H. parainfluenzae = 1% (ET); 4% (NPD)
P. fluorescens = 1% (ET); 4% (NPD)
Kosikowska et al. [18],
2015 164; 328 Range: 2–5 Spectrophotometry
BP Haemophilus species in
97% of patients.
67% of H. influenzae samples were biofilm
producers
56% of H. parainfluenzae samples were
biofilm producers
86% of other H. spp samples were biofilm
producers
Tsou et al. [19], 2015 32; - Range: 4–13 Scanning electronmicroscopy
BP β-lactam-resistant Haemophilus influenzae type b more frequently
detected in children with chronic adenoiditis than in those with adenoidal
hypertrophy without infections.
SD: standard deviation; B: biopsy; NPS: nasopharyngeal swab; SEM: scanning electron microscopy; PAS: periodic acid–Schiff stain; FISH: fluorescence in situ hybridisation; BPB:
biofilm-producing bacteria; BPO: biofilm-producing otopathogens; BP: biofilm-producing; ET: near the Eustachian tube orifice; NPD: at the “nasopharyngeal dome” [11].
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There is no unanimous consensus concerning the preferred sampling technique as both adenoidal
biopsies and nasopharyngeal swabs have been used, although the former has led to higher rates of
positive findings. The well-known resistance of biofilms to mechanical injury reduces the negative
predictive value of nasopharyngeal swabs in detecting biofilms [9], but the rate of adenoidal biofilm
detection can also vary significantly in the case of bioptic specimens, probably because of the different
methods used for fixation and histological processing. As the direction of mucociliary clearance leads
to uneven biofilm distribution on the mucosal layer, the biofilm detection rate is higher in the caudal
than the cephalic or middle sections [17]. Moreover, the traditional fixation method used during
histological processing leads to the dispersion of sessile biofilms attached to the top of a fold on the
nasopharyngeal surface, whereas the planktonic biofilm embedded in deep areas is preserved, because
it is not subject to the actions of nasopharyngeal mucous flow [17].
Finally, the variability in detection rates of bacterial biofilm among patients with chronic adenoiditis
may also be partially due to the different microbiological techniques used to detect them. Advanced
but expensive electron microscopy techniques can more accurately evaluate the complex 3-dimensional
structure of biofilm than the easier-to-use spectrophotometry technique, which can be used to quantify
bacterial adhesion [9–13].
3. Nasopharyngeal Bacterial Biofilm: Is There A Correlation between Adenoiditis and
Recurrent/Chronic Middle Ear Infections?
The literature search was based on the terms “biofilm AND otitis”. Eighteen [20–31] of the 65
initially identified papers concerning recurrent/chronic middle ear disease with a total of 456 patients
(Figure 2) were included.
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Figure 2. Flowchart of article selection (biofilms in recurrent/chronic middle ear disease).
The microbiological analyses of middle ear specimens (i.e., middle ear fluid/mucosa) conducted
by spectrophotometry or other advanced microbiological techniques (scanning electron microscopy,
fluorescence in situ hybridisation).
Biofilm involvement was detected in a variable proportion of patients with recurrent/chronic
otitis media (0%–100%), depending on the case series and type of middle ear disease investigated: in
0%–100% of the adenoidal and/or middle ear samples collected from patients with OME; in 70%–80%
of those taken from patients with RAOM; and in 83%–100% of those taken from patients with CSOM.
The main bacteria involved were those listed above. Table 2 shows the main characteristics of the
selected case series and the related microbiological findings.
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Table 2. Main characteristics and related microbiological findings of the main studies of bacterial biofilm in recurrent/chronic middle ear diseases.
Authors; Year No. of Patients;Samples
Mean Age ± SD,
Years Disease
Analytical
Technique
Prevalence of
Bacterial Biofilm (%) Prevalence of Isolated BPB
Homoe et al. [20], 2009 10; 13 Range: 2–15 CSOMOME
Peptide nucleic
acid-FISH of MEM
and MEF
83%
0%
S. aureus = 67%
S. maltophilia = 17%
Zuliani et al. [21], 2009 68; 68 Range: 3 months–15years
RAOM
OSA
SEM of adenoidal
mucosa
93% of adenoidal mucosa covered by biofilm in children with RAOM; 1%
of adenoidal mucosa covered by biofilm in children with OSA
Hoa et al. [22], 2010 30; 30 Range: 9 months–10years
RAOM
OME
OSA
SEM of adenoidal
mucosa
98% of adenoidal mucosa covered by biofilm in children with RAOM;
28% of adenoidal mucosa covered by biofilm in children with OME; and
<1% of adenoidal mucosa covered by biofilm in children with OSA
Saylam et al. [23], 2011 17; 17 7.5 ± 2.6 OME SEM of adenoidalmucosa 100% -
Nistico et al. [24], 2011 35; - 4.1 (range: 1–10) COMOSA
CLSM and FISH of
adenoidal mucosa
H. influenzae, S. pneumoniae, S. aureus polymicrobic biofilm in most
samples
Daniel et al. [25], 2012 42; 62 Median: 4.5 (range:1–75) OME CLSM of MEM 49%
Coagulase-negative staphylococci = 3
S. aureus = 2
S. pneumoniae = 3
Bacillus spp. = 2
M. catarrhalis = 2
Pseudomonas spp. = 5
Other = 14
Saafan et al. [26], 2013 100; - 5.7 (range: 3–14) OME
SEM and multiplex
PCR of adenoidal
mucosa and MEM
74% (adenoidal
mucosa) -
Thornton et al. [27], 2013 24; 38 Median: 17.9 (range:9.7–36.0) months RAOM FISH on MEM 70%
S. pneumoniae = 73
H. influenzae = 65
M. catarrhalis = 27
S. aureus = 27
P. aeruginosa = 4
Szalmas et al. [28], 2013 59; - 5.1 (range: 3–11)
RAOM
OME
OSA
Hematoxylin-eosin
and Gram staining of
adenoidal mucosa
80%
0%
6%
-
Van Hoecke et al. [29],
2016 21; 34 3.3 (range: 1.1–6.6) OME
FISH and CLSM of
MEE 62% H. influenza biofilm
Tawfik et al. [30], 2016 40; - Range: 1–16 OME SEM of adenoidalmucosa 100% -
De la Torre et al. [31],
2018 10; 20 10 (range: 6–17) Cholesteatoma
CLSM of
cholesteatoma 100% -
SD: standard deviation; BPB: biofilm-producing bacteria; SEM: scanning electron microscopy; CLSM: confocal laser scanning microscopy; FISH: fluorescence in situ hybridisation; PCR:
polymerase-chain reaction; MEM: middle ear mucosa; MEF: middle ear fluid; OME: chronic otitis media; RAOM: recurrent acute otitis media; OSA: obstructive sleep apnoea; COM: chronic
otitis media (unless otherwise specified); CSOM: chronic suppurative otitis media.
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The pathogenic role of bacterial biofilms in the development of chronic adenoiditis and middle ear
disease still remains controversial, as, on one hand, it is supported by the detection of biofilms in a large
prevalence of samples taken from the adenoids/nasopharynx of otitis-prone children (mainly children
with RAOM and CSOM) [20–26,28,30,33–41] (Table 2). On the other hand, some papers show a reduced
rate of nasopharyngeal/adenoidal biofilm involvement especially in children with OME [20,22,25,28].
Some electron microscopy studies have documented the massive distribution of biofilm on the surface
of the adenoids of otitis-prone children who are candidates for adenoidectomy [12,13], and it has been
reported that more than 93% of the adenoidal surface is occupied by biofilm in children with RAOM,
whereas only 1% is involved in children undergoing surgery because of sleep disordered breathing.
The prevalence of adenoidal biofilms in children with a history of severe RAOM (defined as the
presence of four acute otitis media episodes within a period of six months, or six in 12 months) is
higher than that in children with sleep disordered breathing related to adenoidal hypertrophy but
not to a history of middle ear infections [24]. Furthermore, the role of nasopharyngeal biofilms in
favouring the development of non-severe RAOM was documented by Torretta et al. [13], who found
that the rate of otopathogenic biofilms in the nasopharynxes of 58 children with non-severe RAOM
was higher than that found in 55 healthy controls (about 41% vs. 14%).
It has also been found that there is a variable prevalence of otopathogenic biofilms in specimens
of middle ear mucosa/fluid taken from patients with persistent middle ear infections [34]; this suggests
their involvement in the pathogenesis of persistent OME, only in some cases. Although OME was
once considered bacteriologically sterile because of the difficulty of detecting pathogens by means
of traditional culturing methods, the use of the polymerase chain reaction has led to the detection
of bacterial DNA in the middle ear fluid of patients with persistent OME [36], and more recently,
the discovery of bacterial mRNA in the middle ear mucosa of patients with OME has confirmed the
bacterial hypothesis by documenting the presence of replicative bacteria [37]. The role of otopathogenic
biofilms colonising the middle ear in the development of persistent OME is now considered, and
scanning electron microscopy or confocal laser scanning microscopy studies of middle ear samples
from children with OME have reported biofilm detection rates ranging from 40% to 92% [25,37].
However, the precise relationship between nasopharyngeal biofilms and OME is still unclear, and
the published findings are conflicting. Saafan et al. [26] and Saylam et al. [23] described a greater
prevalence of adenoidal biofilm in children with OME than in controls, whereas Hoa et al. [22] found
lower prevalence of nasopharyngeal biofilm in children with persistent OME than in children with
RAOM (28% vs. 99%).
Bacterial biofilms are also thought to be involved in the pathogenesis of chronic middle ear
infections as they have been found in 43%–92% of middle ear specimens from patients with persistent
perforations of the tympanic membrane leading to chronic middle ear suppuration (CSOM) [20,34,38,39]
and in 75%–85% of specimens taken from patients with complicated disease sustained by the presence
of dangerous chronic otitis media with cholesteatoma [20,33,39].
Regardless of whether otopathogenic nasopharyngeal and middle ear biofilms are involved in the
development of chronic adenoiditis, RAOM or persistent OME, it is clear that the middle ear biofilms
produced by S. aureus and P. aeruginosa play a pivotal role in CSOM [17] and chronic otitis media with
cholesteatoma [20,34,35,38,39].
Finally, Moriyama et al. [40] hypothesised that bacterial biofilms are also responsible for the
development of acute otitis media on the basis of the detection of biofilms produced by clinically
non-typeable H. influenzae in patients with acute middle ear infections. This may explain the failure
of traditional antibiotic treatment to cure patients with AOM, which may be related to the fact that
otopathogens can produce biofilms rapidly in favourable environments [35]. However, this theory
is still debated, as a study by Mizrahi et al. [41] failed to find any significant correlation between
the presence of biofilm produced by non-typeable H. influenza and treatment failure or infectious
recurrences in patients with AOM. These findings were supported by Osgood et al. [42], who suggested
that the aerobic conditions occurring during AOM episodes may limit biofilm formation.
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All of the above suggest a possible link between biofilm-related adenoiditis and chronic middle
ear infections, whereas middle ear involvement is probably secondary to the colonisation of the
middle ear mucosa by nasopharyngeal biofilm-producing otopathogens, which periodically spread
in their planktonic forms during any acute infectious exacerbation. The subsequent migration of
bacterial strains through an impaired Eustachian tube (due to the obstruction of its orifice by enlarged
adenoidal pads) may lead to their adhesion to the middle ear mucosa and their subsequent sustenance
of an independent chronic suppurative process whose periodic acute activation may be related to an
autonomous middle ear biofilm. Despite this, given the high variability in detection rates and the fact
that most previous studies did not evaluate the direct virulence of biofilm producers, no definitive
conclusions about the pathogenic role of nasopharyngeal/adenoidal biofilm in the development of
middle ear disease can be drawn.
4. Topographic Distribution of Bacterial Biofilms in the Nasopharynx.
The different distribution of bacterial biofilms on the mucosal layer of adenoidal pads was
investigated by Torretta et al. [11], who collected bioptic specimens for spectrophotometric analysis
from the “nasopharyngeal dome” (i.e., the upper portion of the nasopharynx) and near the Eustachian
tube orifice of children who were candidates for adenoidectomy because of chronic adenoiditis and
persistent or chronic middle ear infections in order to investigate whether the two sites were different
in terms of the prevalence of biofilm-producing otopathogens, the type of pathogens and the biofilm
production capacity [11]. Biofilm-producing bacteria were detected in about 72% of the specimens from
near the Eustachian tube orifice and about 53% of the specimens from the “nasopharyngeal dome”;
S. pneumoniae and M. catarrhalis were more frequently isolated near the Eustachian tube orifice, and
S. aureus was more frequently found at the “nasopharyngeal dome”, but the difference in strains was
not statistically significant (Figure 3). However, the bacterial biofilms located near the Eustachian tube
orifice were more frequently polymicrobial than those at the “nasopharyngeal dome”, thus suggesting
that they were also more virulent [11].
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Figure 3. Total surface area of S. aureus biofilm after 48 hours (my = thickness measurement sides) as
revealed by confocal laser scanning microscopy of an adenoidal specimen.
It can therefore be speculated that chronically infected and enlarged adenoids (particularly when
the adenoidal pads extend toward the Eustachian tube orifice) are sources of otopathogenic biofilms
that periodically release planktonic species that are capable of colonising the Eustachian tube and then
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the middle ear mucosa. This suggests that surgical debridement during adenoidectomy needs to be as
complete as possible (taking particular care to avoid any residues near the Eustachian tube orifice) in
order to avoid biofilm survival in any persistent nasopharyngeal infectious focus.
It has also been reported that nasopharyngeal biofilm-producing otopathogens are more prevalent
in the nasopharynxes of young children with RAOM (but not chronic adenoiditis) than in healthy
controls, which suggests that nasopharyngeal biofilms are independently involved in the development
of recurrent middle ear infections regardless of the presence of adenoidal hypertrophy [13], which
generally affects children aged > 3 years.
5. Conclusions
Taken together, the current evidence documents the large prevalence of bacterial biofilms in
adenoidal and middle ear samples taken from children with chronic adenoiditis with or without
middle ear disease. This finding could suggest that otopathogenic nasopharyngeal biofilm is involved
in the development and perpetuation of chronic adenoiditis. Subsequently, chronic biofilm-sustained
adenoiditis may act as a possible risk factor to exacerbate adenoiditis-associated middle ear infections
by predisposing some patients to developing independent and recalcitrant recurrent or chronic middle
ear diseases such as RAOM, CSOM, and chronic otitis media associated with cholesteatoma. The
involvement of bacterial nasopharyngeal/adenoidal biofilm in OME is questionable. In addition, in
most studies, it is unclear whether biofilm producers are indeed highly and potentially virulent due
to as over-producing toxins, having high biological fitness and/or being highly adhesive, or whether
biofilm is solely generated as a result of repeated or chronic infections, when then act as dormant cells.
Therefore, no definitive conclusions about the pathogenic role of nasopharyngeal/adenoidal biofilm in
the development of middle ear disease can be drawn.
Surgical debridement is still the treatment of choice for eradicating nasopharyngeal biofilms, but
scientific efforts should be made to test alternative non-surgical treatment strategies.
6. Key Concepts
1. Chronic adenoiditis frequently occurs in paediatric patients and is often complicated by the
subsequent development of recurrent or chronic middle ear diseases.
2. The adenoids and surrounding nasopharynx may be sources of otopathogenic biofilms that
periodically release planktonic species that are capable of colonising middle ear mucosa through
an impaired Eustachian tube, thus predisposing individuals to the development of chronic
nasopharyngeal and middle ear infections.
3. The main pathogens involved in nasopharyngeal biofilm production are the so-called otopathogens
(Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae).
4. Given the specific topographic distribution of nasopharyngeal biofilm on adenoidal pads, adenoids
should be carefully resected in the case of chronic nasopharyngeal infection, taking particular care
to avoid any residues near the ostium of the Eustachian tube in order to avoid biofilm survival in
any persistent nasopharyngeal infectious focus.
5. As nasopharyngeal biofilm-producing otopathogens seem to be also involved in the development
of RAOM in young children without adenoidal hypertrophy, it can be speculated that
nasopharyngeal biofilms are independently involved in the development of recurrent middle ear
infections, regardless of the presence of adenoidal hypertrophy.
6. Future studies should investigate the potential virulence of biofilm-producers in the adenoids of
otitis-prone children.
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